CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-16 | Caracciolo Anthony Director | Returned to the company · Warrants (right to buy) | −666,666 | 0 | ||
| 2018-11-16 | Caracciolo Anthony Director | Returned to the company · Warrants (right to buy) | −200,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company | −161,489 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company | −15,750 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −200,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −500,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −54,545 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −200,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −650,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −304,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −600,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −300,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −600,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −350,000 | 0 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Returned to the company · Stock Options (right to buy) | −1,000,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company | −5,304,490 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −50,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −50,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −25,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −50,000 | 0 |
Page 31 of 33 · 652 trades